Kantrex en es it fr

Kantrex Brand names, Kantrex Analogs

Kantrex Brand Names Mixture

  • No information avaliable

Kantrex Chemical_Formula


Kantrex RX_link


Kantrex fda sheet

Kantrex msds (material safety sheet)

Kantrex MSDS

Kantrex Synthesis Reference

No information avaliable

Kantrex Molecular Weight

484.499 g/mol

Kantrex Melting Point

No information avaliable

Kantrex H2O Solubility

No information avaliable

Kantrex State


Kantrex LogP


Kantrex Dosage Forms

No information avaliable

Kantrex Indication

For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.

Kantrex Pharmacology

Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Kantrex Absorption

No information avaliable

Kantrex side effects and Toxicity

LD 50 - ORAL, MOUSE = 17500 MG/KG, LD 50 - ORAL, RAT = >4 GM/KG, LD 50 - ORAL, RABBIT = >3 GM/KG

Kantrex Patient Information

No information avaliable

Kantrex Organisms Affected

Enteric bacteria and other eubacteria